biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
17:34 Unusually low or high hemoglobin on routine blood tests tied to dementia✦17:33 Three-drug mix kept advanced melanoma in check far longer in a trial✦05:37 Some breast cancer patients skipped chemo; 92% stayed disease-free 5 years✦05:32 Blood test flagged Alzheimer's-linked memory decline up to 10 years ahead✦11:34 FDA gives quick approval to DNA treatment to cut repeat airway surgeries✦05:38 Testosterone showed no clear memory boost after menopause, review finds✦05:36 Scalp gel that aims to wake hair follicles will be tested in 200 women✦05:33 Lilly's experimental weight-loss shot cut sleep apnea breathing pauses✦17:34 Unusually low or high hemoglobin on routine blood tests tied to dementia✦17:33 Three-drug mix kept advanced melanoma in check far longer in a trial✦05:37 Some breast cancer patients skipped chemo; 92% stayed disease-free 5 years✦05:32 Blood test flagged Alzheimer's-linked memory decline up to 10 years ahead✦11:34 FDA gives quick approval to DNA treatment to cut repeat airway surgeries✦05:38 Testosterone showed no clear memory boost after menopause, review finds✦05:36 Scalp gel that aims to wake hair follicles will be tested in 200 women✦05:33 Lilly's experimental weight-loss shot cut sleep apnea breathing pauses
← All story threadsSTORY THREAD

Three-drug first treatment for BRAF melanoma.

1 report so far. New developments are added to this thread as they happen.

  1. Oct 31, 2026
    FINAL TRIAL RESULTS PRESENTED AT A CANCER CONGRESSControlled trial · melanoma

    Three-drug mix kept advanced melanoma in check far longer in a trial

    Two targeted pills added to Keytruda shrank tumors in 70% of people with a gene-driven skin cancer. It also brought more serious side effects, and a survival gain is not yet confirmed.